S. E. Salmon
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Erythropoietin and Anemia Treatment
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
Papers in
- Hematology 13
- Multiple Myeloma Research and Treatments 11
- Oncology 16
- Cancer Treatment and Pharmacology 9
- Co-authors
- Stephen E. Jones (3 shared papers)Thomas M. Grogan (2 shared papers)R J Scheper (2 shared papers)William S. Dalton (4 shared papers)TP Miller (1 shared paper)Catherine M. Spier (1 shared paper)David Samuel Alberts (6 shared papers)Teruko Ishizaka (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)JNCI Journal of the National Cancer Institute (4 papers)The Lancet (3 papers)Recent results in cancer research (2 papers)Journal of Pharmaceutical Sciences (2 papers)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
S. E. Salmon
38 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 104
- Hematology 550
- Oncology 946
- Genetics 145
- Immunology 220
- Cancer Research 147
Countries citing papers authored by S. E. Salmon
This map shows the geographic impact of S. E. Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. E. Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. E. Salmon more than expected).
Fields of papers citing papers by S. E. Salmon
This network shows the impact of papers produced by S. E. Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. E. Salmon. The network helps show where S. E. Salmon may publish in the future.
Co-authors
The 25 scholars most cited alongside S. E. Salmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 346 | |
| 2 | Adjuvant Therapy of Cancer | 1990 | 243 |
| 3 | Biologic activities of aggregated gamma-globulin. 8. Aggregated immunoglobulins of different classes. | 1967 | 203 |
| 4 | 1989 | 185 | |
| 5 | 1993 | 174 | |
| 6 | 1978 | 80 | |
| 7 | 1978 | 79 | |
| 8 | 1980 | 78 | |
| 9 | 1986 | 74 | |
| 10 | 1976 | 49 | |
| 11 | 1987 | 47 | |
| 12 | 1978 | 46 | |
| 13 | Model for estimation of clinically achievable plasma concentrations for investigational anticancer drugs in man. | 1986 | 45 |
| 14 | 1989 | 40 | |
| 15 | Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study. | 1982 | 29 |
| 16 | A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin. | 1991 | 29 |
| 17 | 1984 | 24 | |
| 18 | 1985 | 22 | |
| 19 | 1973 | 21 | |
| 20 | 1984 | 18 |
About S. E. Salmon
S. E. Salmon is a scholar working on Hematology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Molecular Biology, having authored 44 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (11 papers), Cancer Treatment and Pharmacology (9 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Genomics and Diagnostics (3 papers), Protein Degradation and Inhibitors (3 papers), Zoonotic diseases and public health (2 papers) and Computational Drug Discovery Methods (2 papers). The work is most often cited by research in Hematology (550 citations), Oncology (946 citations), Genetics (145 citations), Immunology (220 citations) and Cancer Research (147 citations). S. E. Salmon has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Stephen E. Jones, Thomas M. Grogan, R J Scheper, William S. Dalton, TP Miller, Catherine M. Spier, David Samuel Alberts, Teruko Ishizaka, Kimishige Ishizaka and H. Hugh Fudenberg. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, The Lancet, Recent results in cancer research and Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.